503 related articles for article (PubMed ID: 22446691)
1. Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research.
Wang K; Xie S; Ren Y; Xia H; Zhang X; He J
Oncol Rep; 2012 Jun; 27(6):1981-9. PubMed ID: 22446691
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
[TBL] [Abstract][Full Text] [Related]
3. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
4. [Establishment of a whole-body visualization model of breast cancer with high hepatic metastatic potential in nude mice through serial passage in vivo].
Yang M; Yang ZH; Hou ZD; Li XN
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):944-7. PubMed ID: 18583234
[TBL] [Abstract][Full Text] [Related]
5. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
6. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
7. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
Schubert A; Hawighorst T; Emons G; Gründker C
Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of tumor transduced with bimodal lentiviral vector encoding human ferritin and green fluorescent protein on a 1.5T clinical magnetic resonance scanner.
Kim HS; Cho HR; Choi SH; Woo JS; Moon WK
Cancer Res; 2010 Sep; 70(18):7315-24. PubMed ID: 20823165
[TBL] [Abstract][Full Text] [Related]
10. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
[TBL] [Abstract][Full Text] [Related]
11. Stable transgene expression in tumors and metastases after transduction with lentiviral vectors based on human immunodeficiency virus type 1.
Bao L; Jaligam V; Zhang XY; Kutner RH; Kantrow SP; Reiser J
Hum Gene Ther; 2004 May; 15(5):445-56. PubMed ID: 15144575
[TBL] [Abstract][Full Text] [Related]
12. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
13. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
14. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
15. Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2.
Zhang KX; Kim C; Chow E; Chen IS; Jia W; Rennie PS
Breast Cancer Res Treat; 2011 Jan; 125(1):89-97. PubMed ID: 20232140
[TBL] [Abstract][Full Text] [Related]
16. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects.
Ray P; Tsien R; Gambhir SS
Cancer Res; 2007 Apr; 67(7):3085-93. PubMed ID: 17409415
[TBL] [Abstract][Full Text] [Related]
18. Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Seitz S; Buchholz S; Schally AV; Jayakumar AR; Weber F; Papadia A; Rick FG; Szalontay L; Treszl A; Köster F; Ortmann O; Hohla F
Anticancer Drugs; 2013 Feb; 24(2):150-7. PubMed ID: 23080077
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946
[TBL] [Abstract][Full Text] [Related]
20. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells.
Kim SY; Lee IS; Moon A
Chem Biol Interact; 2013 May; 203(3):565-72. PubMed ID: 23562496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]